The Project

NV-doped diamond for a better diagnostic of cardiovascular diseases

 

Cardiovascular diseases are one of the most common causes of death worldwide. Therefore, it is necessary to develop personalized medical solutions to improve the chances of curing patients. In order to do so, the metabolic process of heart tissue needs to be understood and observed on a molecular level.

Current methods do not allow this in high resolution, and they furthermore rely on radioactive substances. Quantum technology offers a new approach: the project develops an innovative diamond polarizer that is able to work at room temperature with a 160-times higher efficiency, offering a polarization that is 40-times faster and 4-times cheaper than before. By those means, quantum technology is being utilized for human needs.

Project title MetaboliQs - Leveraging unparalleled room temperature quantum coherence to enable safe, first-of-its-kind, multimodal cardiac imaging
Project duration 2019 – 2021
Project Management Fraunhofer-Institut für Angewandte Festkörperphysik (IAF)
Funding source EU - FET Flagship on Quantum Technologies
Project coordinator Dr. Christoph Nebel (IAF), M.Sc Ilai Schwartz (NVIS)
Projekt partners
  • NVision Imaging Technologies GmbH (NVIS), Germany
  • Technical University of Munich (TUM), Germany
  • Swiss Federal Institute of Technology (ETH), Swizerland
  • Bruker BioSpin GmbH (BBS), Germany
  • Element Six (UK) Limited (E6), United Kingdom
  • The Hebrew University of Jerusalem (HUJI), Israel

PROJECT:

Quantum Metrology and Sensing

THEME:

Quantum Technologies

DURATION:

October, 2018 to September, 2021

BUDGET:

6,667,801.25 €

CALL IDENTIFIER: 

Horizon 2020, Call: H2020-FETFLAG-2018-2020 (FET FLAGSHIPS – Tackling grand interdisciplinary science and technology challenges), Topic: FETFLAG-03-2018, Type of action: RIA
This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 820374.

This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 820374.